The immunohistochemical data of SLC25A24 in different cancer tissue from the Human Protein Atlas showed that SLC25A24 had higher expression in 16 types of cancer including breast invasive cancer, colon adenocarcinoma, lung squamous cell carcinoma, prostate adenocarcinoma, stomach adenocarcinoma, thyroid carcinoma, and uterine corpus endometrial carcinoma (Figure 3(b)). Here, SLC25A24 is linked to prostate adenocarcinoma.